REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Clinical trial NCT07675824 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07675824
Sponsor: Regeneron Pharmaceuticals
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Open Angle Glaucoma (POAG)Ocular Hypertension (OHT)

Start date: 2026-07-23
Primary completion: 2029-07-25
Enrollment: 271

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.